Ability of practitioners to identify solid oral dosage tablets
- PMID: 16638948
- DOI: 10.2146/ajhp050336
Ability of practitioners to identify solid oral dosage tablets
Abstract
Purpose: Physicians' and pharmacists' ability to correctly identify three commonly used oral dosage forms was assessed.
Methods: A list of physicians and pharmacists was obtained from two urban teaching hospitals. A total of 100 pharmacists and physicians were randomly selected and their ability to correctly identify three commonly used tablets was tested. Participants were also asked about their experiences and views on current resources and alternatives for identifying oral dosage forms. Tablet-identification exercises were performed by physicians and pharmacists in their usual practice settings. Participants could consult the resources usually available to them for the identification of unknown medications.
Results: A total of 300 observations were made in the tablet-identification exercise (100 participants, three tablets per participant). The tablet was correctly identified in 190 of the observations (63%). The brand-name tablet, the generic tablet, and the nonprescription generic tablet were correctly identified in 78%, 64%, and 48% of the observations, respectively. Only 18 physicians (36%) and 24 pharmacists (48%) correctly identified all three tablets, whereas 10 physicians (20%) and 5 pharmacists (10%) could not correctly identify any of the tablets. The mean time required to identify a tablet was 3.65 minutes. Pharmacists most often used electronic resources (52%), while physicians relied on print resources. Overall, 77% expressed dissatisfaction with the current system and 91% favored a universal imprint coding system for oral dosage forms.
Conclusion: Physicians and pharmacists failed to correctly identify three commonly prescribed tablets more than a third of the time. The brand-name tablet was correctly identified more often than were the prescription generic and nonprescription generic products.
Comment in
-
Issues in medication safety.Am J Health Syst Pharm. 2007 Jan 1;64(1):21-2; author reply 24. doi: 10.2146/ajhp060268. Am J Health Syst Pharm. 2007. PMID: 17189568 No abstract available.
-
Issues in medication safety.Am J Health Syst Pharm. 2007 Jan 1;64(1):21; author reply 22, 24. doi: 10.2146/ajhp060212. Am J Health Syst Pharm. 2007. PMID: 17189569 No abstract available.
-
Issues in medication safety.Am J Health Syst Pharm. 2007 Jan 1;64(1):22; author reply 24. doi: 10.2146/ajhp060243. Am J Health Syst Pharm. 2007. PMID: 17189571 No abstract available.
Similar articles
-
Evaluation of electronic databases used to identify solid oral dosage forms.Am J Health Syst Pharm. 2003 Sep 1;60(17):1735-40. doi: 10.1093/ajhp/60.17.1735. Am J Health Syst Pharm. 2003. PMID: 14503109
-
Drug identification by the patient: Perception of patients, physicians and pharmacists.Therapie. 2019 Dec;74(6):591-598. doi: 10.1016/j.therap.2019.03.003. Epub 2019 Apr 2. Therapie. 2019. PMID: 31014975
-
Potency of brand name and generic levothyroxine.JAMA. 1980 Oct 10;244(15):1704-5. JAMA. 1980. PMID: 7411829
-
A Systematic Review of Physicians' and Pharmacists' Perspectives on Generic Drug Use: What are the Global Challenges?Appl Health Econ Health Policy. 2015 Aug;13 Suppl 1(Suppl 1):S35-45. doi: 10.1007/s40258-014-0145-2. Appl Health Econ Health Policy. 2015. PMID: 25963230 Free PMC article. Review.
-
Review of bilayer tablet technology.Int J Pharm. 2014 Jan 30;461(1-2):549-58. doi: 10.1016/j.ijpharm.2013.12.028. Epub 2013 Dec 24. Int J Pharm. 2014. PMID: 24370841 Review.
Cited by
-
Prescription stimulant brand name recognition among a national sample of 10- to 18-year-old youth.Int J Methods Psychiatr Res. 2021 Dec;30(4):e1884. doi: 10.1002/mpr.1884. Epub 2021 Jul 10. Int J Methods Psychiatr Res. 2021. PMID: 34245080 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
